CD8A and neoplasm: In the absence of viral replication (46–49), these results suggest that IT administration of low doses of MMR can modulate the immune compartment of the tumor microenvironment by increasing the subset of CD8+ GranzymeB+ TILs and decreasing the frequency of macrophage populations within the tumor.